Location History:
- Kawasaki, JP (2001)
- Kanagawa, JP (2017)
Company Filing History:
Years Active: 2001-2024
Title: Nobukazu Ono: Innovator in Pancreatic and Lung Cancer Evaluation
Introduction
Nobukazu Ono is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical technology, particularly in the evaluation of pancreatic and lung cancer. With a total of 3 patents, Ono's work is at the forefront of cancer diagnostics.
Latest Patents
Ono's latest patents include a method for evaluating pancreatic cancer, a pancreatic cancer evaluating apparatus, and a pancreatic cancer evaluating program product. His innovative method involves obtaining amino acid concentration data from blood samples of subjects. This data is then used to evaluate the state of pancreatic cancer by calculating a value using a previously established formula. The formula incorporates concentration values of various amino acids, including Asn, His, Thr, and others. Additionally, he has developed a lung cancer evaluating apparatus and method that also relies on amino acid concentration data to assess the lung cancer state in subjects.
Career Highlights
Nobukazu Ono is currently employed at Ajinomoto Co., Ltd., where he continues to advance his research in cancer evaluation technologies. His work has the potential to significantly improve early detection and treatment options for patients suffering from these diseases.
Collaborations
Ono collaborates with notable colleagues, including Naoyuki Okamoto and Masahiko Higashiyama. Their combined expertise enhances the research and development of innovative solutions in cancer diagnostics.
Conclusion
Nobukazu Ono's contributions to cancer evaluation technology exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving diagnostic methods, ultimately benefiting patients and the medical community.